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• Pneumonia CMS “Core Measures” form 
• COPD form 
• Heart Failure (CHF) CMS “Core Measures” form 
• Ischemic Stroke form 
• Alcohol Withdrawal form 
 
 
Translated Patient  
Education Materials 
 
Before you invest hours and dollars in translating 
patient education materials into other languages 
(Spanish, Hmong, Laotian or Somali), check out 
the resources already translated on the CentraNet 
under the Patient Care, Education or Diversity tab 
named "Translated Patient Education Materials."   
 
Over 75 documents including consents, diseases, 
medications, treatment options, and dialysis 
procedures have been translated into different 
languages and are available just a telephone call 
away.  Check it out! 
 
Pam Rickbeil, RN 
Education 
 




7 Cardiology Seminar (The Power of 
Walking; Taking Steps to Build a 
Healthier, More Livable Community) 
Community event 
7 Cardiology Seminar, Windfeldt  




22/23 Emergency Nursing Pediatric Course, 
Conference Center 
28 Endoscopy Conference, Windfeldt 
Room 
28/29 ONS Cancer Chemotherapy Course, 
Fireside Room/Aspen Room 
28/29 Trauma Nursing Core Course, 
Conference Center 
 
For more details, call the Education 
Department at Ext. 55642. 
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Magnet Force #9 – Autonomy 
Description:  Nurses are permitted and expected to practice autonomously, consistent with professional 
standards.  Independent judgment is expected to be exercised within the context of a multidisciplinary 
approach to patient care. 
 
We are looking for: 
• Direct care RNs (at least 50% of the time spent at the bedside) using professional standards, 
literature and research findings to support control over nursing practice 
• How nurses use independent decision making, assertiveness and leadership in the patient care 
environment. 
• How changes in practice are supported by professional standards, literature and research. 
• How patient care outcome issues are identified by direct care RNs and how they were addressed. 
 







Magnet Force #10 – Community and Hospital 
Description: St. Cloud Hospital has a strong community presence in 
ongoing, long term outreach programs with SCH perceived as a 
strong, positive, productive corporate citizen.  Development and 
support of strong partnerships among all types of healthcare 
organizations for improved patient outcomes and the health of the 
community. 
 
We are looking for stories and examples about: 
• List of partnerships established between SCH and community based entities 
to advance nursing practice. 
• List of partnerships established between SCH and community-based entities to meet the healthcare 
needs of populations served. 
• Examples of awards or recognition’s received by the facility or any nurses for community support or 
involvement. 
• Examples of programs and outcomes that have resulted from nursing collaborations/partnerships 
with other nursing entities in the community or region. 
 
Force #10 – Force Leader 
 Carolyn Neubauer 
Educator 




Anne Gagliardi, RN, BSN 
Surgery 
Ext. 55618 
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New “Medical/Critical Care 
Admission Orders”  
and “Evidence - Base” 




Several months ago a multi-discipline group met 
to streamline admission orders that are currently 
available for medical patients and to revise 
select “pre-printed” orders into protocols. 
This work has resulted in a Medical/Critical 
Care Admission Order (attached) and 5 
Evidence-Based Protocols. These protocols 
are: 
 
1. Pneumonia CMS “Core Measures” 
incorporated (see attached) 
2. COPD (see attached) 
3. Heart Failure (CHF) CMS “Core 
Measures” incorporated (see attached) 
4. Ischemic Stroke (see attached) 
5. Alcohol Withdrawal (see attached) 
 
In July, 2005 the Hospitalist group began to trial 
the admission order set and protocols.  After 
completion of this trial, feedback was reviewed 
by nursing staff, HUC’s and physician groups.  
Final revisions were brought to the Medical 
Executive Committee and Department of 
Medicine in November, 2005 with final approval 
to implement. 
 
These orders/protocols are currently “not 
mandatory”, but highly ENCOURAGED. 
 
• “What happens to the Pre-printed 
Orders?” 
 
EFFECTIVE JANUARY 3, 2006: 
PRE-PRINTED ORDERS for Pneumonia, 
COPD, Heart Failure (CHF), and Alcohol 
Withdrawal and ADMISSION ORDERS for 
Critical Care, Nephrology, and Stroke WILL 
BE DELETED FROM JRS OPTIO AND 
CENTRANET. 
 
• “What responsibilities does the physician 
have when ordering protocols?” 
 
Physicians are responsible for knowing 
what is included on the protocol they 
select.  If a physician does not want a 
particular order, they need to line through 
the order.  
 
• “What do I look for in JRS OPTIO?” 
 
1. Medical Admission Non Critical- Care  
This will print with a medical admission 
order sheet. 
  
2. Medical Admission Critical Care  
This will print with 2 order sheets medical 
admission and critical care admission. 
  
3. Critical Care Admission  
This will print a critical care admission 
order to be used for In-house transfers. 
 
• “Do I need a physician signature on the 
protocol?” 
 
Currently, at the time of admission, the nurse 
will write a VORB/physician _____________.  
The physician will need to sign the order 
during the patient’s stay or after discharge.  
 
Ongoing education will be completed for Critical 
Care, Telemetry, Med/Onc., Ortho/Neuro, ETC 
and Float Pool by their representatives prior to 
implementation.  There will also be weekly 
reminders in JRS up to implementation. 
 
Thank you to all committee members, nursing 
staff, and physicians who gave of their time and 
participated with this project.  A special thanks to 
Deb Wimmer, Diane Gustafson, Robin Sass, 
and Michelle Parson who were instrumental in 
facilitating the operational steps necessary. 
 
Deb Eisenstadt, MS, RN 
Clinical Utilization Specialist 
Ext. 54169 
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Pertussis and the  
Healthcare Setting 
 
With the rise in reported cases of pertussis in 
Minnesota (see “Pertussis Vaccines for 
Adolescents and Adults and Updated 
Treatment and Prophylaxis Recommendations 
on p. 67) has come an increase in the reported 
transmission of the disease within the 
healthcare setting. Pertussis transmission from 
patient to provider and vice versa, including 
large outbreaks in healthcare facilities, has 
been documented in Minnesota and nationally.  
 
Recent Minnesota Department of Health (MDH) 
investigations of pertussis transmission in a 
hospital neonatal intensive care unit and in an 
obstetrics clinic were particularly concerning, as 
infants are at the highest risk for severe and 
potentially fatal pertussis-related complications. 
By promptly recognizing cases, notifying 
patients, and providing prophylaxis to close 
contacts, health officials and healthcare facility 
staff may have prevented secondary cases.  
 
In addition to posing health risks, pertussis is 
costly when it occurs in healthcare workers 
because of lost work time and the considerable 
resources required for the notification and 
prophylaxis of other staff and patients. Recently, 
an outbreak of pertussis occurred in a 
Minnesota healthcare facility, resulting in 17 
confirmed cases in employees. Onsets of the 
illness developed over a 2-month period and 
involved three clusters within the facility, causing 
a tremendous expenditure of time, energy, and 
money to control the spread of the illness. Over 
the course of the outbreak, 687 employees were 
provided antimicrobial prophylaxis, and 510 
patients were notified of possible pertussis 
exposure. The situation also contributed to 
pertussis transmission in the community, as at 
least one healthcare provider transmitted 
pertussis to his/her child, and at least one 
pertussis transmission in a childcare setting was 
linked to the hospital outbreak. 
  
Prevention in the Healthcare Setting  
Pertussis is spread by droplets containing 
Bordetella pertussis bacteria. The droplets 
generally travel no more than 3 feet from the 
infected patient and are deposited on the new 
host’s nasal mucosa, conjunctivae, or mouth. 
Droplets can be generated during coughing and 
sneezing, as well as during the performance of 
certain medical procedures such as a 
nasopharyngeal (NP) swab, aspirate, or wash.  
 
Standard national guidelines state that “close 
contacts” of pertussis patients should be 
provided antimicrobial prophylaxis (See Table 1 
on p. 68). While no national standard definition 
of “close contact” exists, MDH and local health 
department epidemiologists, with extensive 
experience conducting pertussis case 
investigations, have collaboratively agreed to 
define close contact as either 1) direct face-to-
face exposure with an infectious case, or 2) 
exposure for at least 10 hours over a week’s 
time, during which the individual is generally 
within 3 feet (i.e., arm’s length) of a case.  
 
Performing an NP swab, aspirate, or wash on an 
infectious pertussis patient without a surgical 
mask constitutes a close exposure warranting 
prophylaxis. Healthcare providers should take 
droplet precautions (i.e., standard precautions 
and masking) whenever working with an 
unknown respiratory illness. Masking during 
such procedures eliminates the need for post-
exposure prophylaxis and also protects the 
healthcare worker from other respiratory 
illnesses.  
 
Healthcare providers should be mindful of their 
own symptoms, particularly paroxysmal 
coughing or a cough illness lasting longer than 7 
days. When a healthcare worker is diagnosed 
with pertussis within the first 3 weeks of the 
cough illness, the healthcare provider should be 
excluded from work until he or she has 
completed 5 days of appropriate antimicrobial 
treatment. All potentially exposed persons 
should be informed about pertussis symptoms 
and encouraged to seek medical evaluation if 
symptomatic, and asymptomatic close contacts 
should be prescribed a course of antimicrobial 
prophylaxis. When patients are exposed to 
pertussis at a healthcare facility, the facility 
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should assume responsibility for the cost of 
notification, testing, prophylaxis, or treatment, as 
indicated. 
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Need for Collaboration  
Public health agencies and healthcare facilities 
must work collaboratively to adequately address 
pertussis prevention and control. Upon 
identifying pertussis in a patient or healthcare 
worker, healthcare facilities should notify public 
health officials for assistance in identifying close 
contacts and in coordinating contact notification 
and prophylaxis. Conversely, when MDH or local 
public health agencies identify a pertussis 
outbreak in a school or other community setting, 
they should notify healthcare facilities that may 
be affected by the outbreak.  
 
Immunization is a primary pertussis prevention 
and control strategy; however, the current 
practice of vaccinating children younger than 7 
years has not eliminated the reservoir of 
infection, as pertussis remains endemic despite 
high immunization rates. The availability of two 
newly licensed pertussis vaccines for older 
children and adults provides the opportunity to 
expand coverage. (See “Pertussis Vaccines for 
Adolescents and Adults and Updated Treatment 
and Prophylaxis Recommendations” on p. 67.) 
The Advisory Committee on Immunization 
Practices (ACIP) has recommended that older 
children and adults receive the new pertussis 
vaccine when they are due for a tetanus 
diphtheria booster. ACIP is considering 
recommendations for vaccinating targeted 
adults, including healthcare workers.  
 
Resources  
MDH has developed a number of pertussis-
related information pieces targeted to both 
healthcare providers and the general public that 
address various aspects of pertussis 
epidemiology, laboratory testing, treatment and 
prophylaxis, and prevention and control 
measures.   
 
These materials are posted on the MDH Web 
site at www.health.state.mn.us/divs/idepc/diseases/pertussis 
 
Fay Chawla 








Congratulations to the following individuals for 
achieving and/or maintaining their Level III 




Jane Austing, RN OR 
 Revised Procedure Cards 
 Preceptor 
 Practice Committee 
 H-Works Committee 
 
Chelsie Baaken, RN FBC 
 Team Nursing Presentation 
 Preceptor 
 Employee Satisfaction Committee 
 Chair of Employee Satisfaction Committee 
 
Kristin Gaarder, RN Surgical Care 
 Taught Abdominal Surgery Class 
 Preceptor 
 SCRUBS Committee 
 
Sharon Klimek, RN KDA 
 Taught Renal Failure and Treatment 
Options 
 Coordinates Monthly Care Conferences 
 PI Committee Member 
 
Jennifer Krebsbach, RN Imaging 
 PIC Independent Learning Module 
 EPIC Liaison 
 Preceptor 
 DVT Poster 
 Med/Surg Certification 
 
Colleen Layne, RN CSC 
 Edits Weekly Unit Newsletter 
 Preceptor 
 Future Planning Task Force 
 Med/Surg Certification 
 
Elaine Prom, RN CSC 
 New and Revised Standing Orders 
 PI Committee 
 Preceptor 
 Med/Surg Certification 
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Jessica Lund, RN Children’s Center 
 PI Committee 
 Co-wrote Diabetic CCO Care Plan 
 EPIC Liaison 
 PCW Long Range Strategic Planning 
 
Joann Spaulding, RN Telemetry 
 Carotid Stint Module 
 Biphasic Defibulator External Pacemaker 
and Temporary Pacemaker Skill Sets 
 
Carol Steil, RN ICU 
 Nursing Process Group Leader 
 Certified Donor Requestor 
 Preceptor 
 CCNP Committee 
 
Nancy Stiles, RN ETC 
 EPIC Liaison 
 Preceptor 
 Nurse Practice Committee 
 Clinical Ladder Committee 
 
Barb Wagner, RN ETC 
 PI Committee 
 Restraint Poster 
 PALS Instructor 








ALLERGY   NO    YES      WT.          (kg.)  HT.     
IF YES, PLEASE STATE  
PNEUMONIA PROTOCOL 
•  Initiate Pneumonia CCP 
•  Verify blood cultures x 2 drawn prior to initial antibiotic 
Antibiotics: Renal Dosing Protocol Applies per Pharmacy  
 If Community Acquired/Nursing Home   
  • Levofloxacin 750 mg IV/po q 24 hours STAT (Pharmacy to dispense oral dosage form unless otherwise indicated.) 
•  Document smoking cessation counseling if smoked within past 12 months 
•  Pneumococcal Vaccine - administer if ≥ to 65 years of age and patient has not received or is unknown   
•  Influenza Vaccine  (October - February) for patients age 50 years or older administer if patient has not received 
• Sputum for Gram Stain, culture if adequate specimen   
• RN Case Manager Referral 
 
CRITICAL CARE ONLY (Per Critical Care Admission Orders) 
 If Aspiration Pneumonia in Critical Care     
     
  HIGH RISK FOR PSEUDOMONAS  
  Give three antibiotics listed below 
     • Cefepime 2 gm IV q 12 hrs begin STAT  
    • Tobramycin IV per Pharmacy Protocol  
    • Doxycycline 100 mg IV q 12 hrs  
 
 If patient allergic to cephalosporins or anaphylaxis with 
 penicillin, then give two antibiotics listed below: 
• Levofloxacin 750 mg IV q 24 hours STAT 






LOW RISK FOR PSEUDOMONAS   
Give three antibiotics listed below 
 • Cefepime 2 gm IV q 12 hrs begin STAT 
 • Doxycycline 100 mg IV q 12 hrs.   
       May switch to oral when able.   
 
If patient allergic to cephalosporins or 
anaphylaxis with penicillin then give the following 
antibiotic: 
• Levofloxacin 750 mg IV q 24 hours  STAT 











Orders with a checkbox present must be checked off to be implemented.   
Orders without a checkbox present will be implemented unless stricken out. 
Signature:                      
Date:                Time:        
ORDER SHEET  Scanned (Name)             (Date)        (Time)    
Department of Medicine – Revised:  12/20/2005            
85-069-1              
5200063 
 ENDO      KDIP      ETC 





ALLERGY   NO    YES         WT.          (kg.)  HT.      
IF YES, PLEASE STATE  
COPD EXACERBATION PROTOCOL 
•  Initiate COPD CCP 
Medications 
• Methylprednisolone sodium succinate (Solu-Medrol) 125 mg IV q 6 hrs x 4 doses, then change to Prednisone 20 mg (po) BID 
• Metered Dose Inhaler (MDI):  Albuterol/Ipratropium (Combivent) 2 puffs q 4 hrs while awake with spacer (if unable to perform 
  MDI administration, change to Neb) 
• Nebulizer:  Albuterol/Ipratropium 2.5 mg (Duoneb) q 4 hrs while awake and q 2 hrs prn. 
• (If on Pneumonia Protocol, see above) Sulfamethoxazole/TMP DS (Bactrim DS) (po) q 12 hrs.  If sulfa or trimethoprim  
  allergy, then Cefpodoxime 200 mg (po) q 12 hrs.  If oral route not available, then Ceftriaxone 1 gram IV q 24 hrs. 
• Document smoking cessation counseling if smoked within past 12 months on ITR. 
• Dietician Referral per Nutrition Score on FHA. 



















Orders with a checkbox present must be checked off to be implemented.   
Orders without a checkbox present will be implemented unless stricken out. 
Signature:                      
Date:                Time:        
ORDER SHEET   Scanned (Name)             (Date)        (Time)    
Department of Medicine – Revised:  12/16/2005     
85-066-1 5200061 
 ENDO      KDIP      ETC 
Optio     





ALLERGY   NO    YES         WT.          (kg.)  HT.      
IF YES, PLEASE STATE  
HEART FAILURE PROTOCOL 
•  Initiate Heart Failure CCP 
• Ejection fraction    %, date measured       . 
 If never measured, order Echocardiogram (excludes patients on comfort care only). 
 * Ejection fraction can be found under Cardiology tab in CDR in Echocardiogram, TEE, Nuclear Stress Test or Angiogram Reports 
• For LVSD of < 40%, prior to discharge initiate: 
 ACE inhibitor         or indicate contraindication          . 
 or  
 ARB           or indicate contraindication         . 
 *Hold ACE inhibitor/ARB and call physician if two consecutive BP’s (15 min apart) are ≤80 mmHg systolic 
• Contact physician 24 hours prior to anticipated discharge if EF <40% and any of the following occur: 
  1)  ACE inhibitor/ARB not ordered or  
  2)  Contraindication not documented  
Indicate if patient on Beta Blocker:                   
   *Hold med and call physician if any one of the following occur:  
  Two consecutive BP’s (15 min part) are ≤80 mmHg systolic 
         HR <50 bpm 
  Pause ≥2.5 seconds 
 
•  Contact physician 24 hours prior to anticipated discharge if no Beta Blocker ordered or no contraindication documented. 
• Smoking Cessation Consult for history of smoking within the last 12 months. 
• Heart Failure Education packet from Optio and initiate education 
• Case Manager Consult regarding Heart Failure education and case management 
• Dietitian Consult regarding Low Sodium Diet (2500 mg). 
• 2500 mg Na Diet.  Add ADA if diabetic. 
• Vital Signs 
 Daily Weight before breakfast (call physician after 0800 if weight up ≥ 1.5 kg overnight) 
 Orthostatic blood pressure once daily (laying, sitting, and standing)          







Orders with a checkbox present must be checked off to be implemented.   
Orders without a checkbox present will be implemented unless stricken out. 
Signature:                      
Date:                Time:        
ORDER SHEET   Scanned (Name)           (Date)              (Time)     
Department of Medicine – Revised: 12/13/2005   
85-067-1  5200058 




ALLERGY   NO    YES         WT.          (kg.)  HT.      
IF YES, PLEASE STATE  
ISCHEMIC STROKE PROTOCOL 
•  Initiate appropriate CCP. 
•  Aspirin Buffered 325 mg (po) or (R) daily.  Start within 48 hours of onset of stroke symptoms. 
•  Neuro assessment per unit standards 
 Vitals Signs  q 2 hrs x 4, then q 4 hrs until stable, and then QID 
 Neuro Assessment  q 2 hrs, then q 4 hrs until stable, and then QID 
 Check with physician for notification parameters 
  for SBP>                       DBP>                               P>                              T>           
•  Screen for safe swallow before first meal/H2O by mouth.  If swallow impaired, make NPO and consult speech therapy to evaluate  
    and treat for dysphasia.  If swallow not impaired, diet as ordered. 
•  Elimination assessment q shift 
•  Bladder scan q 4-6 hrs prn, straight cath prn for volumes >500 mL or residual void volumes >200 mL.  
•  Foley catheter is recommended prior to TPA administration 
Labs   
 •  Lipid Profile unless already done this admission 
  
•  CT of head if not completed  this admission 
•  12 lead EKG if not completed  this admission 
•  Consult  Case Manager Stroke Center 
•  PT evaluation and treat for any functional deficit 
•  OT evaluation and treat for any functional deficit 
• IV Therapy  
      **Dextrose containing fluids not recommended for first 48 hrs.  **Dextrose may be 
administered in maintenance solutions after  
   24 hrs, but should be avoided in bolus solutions (e.g. volume resuscitation fluids).   








Orders with a checkbox present must be checked off to be implemented.   
Orders without a checkbox present will be implemented unless stricken out. 
Signature:                      
Date:                Time:        
ORDER SHEET  Scanned (Name)              (Date) 
       (Time)    
Department of Medicine – Revised:  12/13/2005      
85-065-1        5200060 
 ENDO      KDIP      ETC 
Optio 
 





ALLERGY   NO    YES         WT.          (kg.)  HT.     
IF YES, PLEASE STATE  
MEDICAL ALCOHOL WITHDRAWAL PROTOCOL  
RN to implement Alcohol Withdrawal Assessment Flowsheet. 
Reassess AM and PM for transfer to    Critical Care  or  MPCU/SPCU   or  Med/Onc  or   MHU 
Mental Health RN Case Manager consult to assess for Social Worker, CD eval, Addictionist 
Labs •  Mg++ each AM until within normal limits x 2 days     •  SGPT    •  PLTS 
Medications: 
•  Initiate Adult Electrolyte Replacement Protocol 
•  Therapeutic multivitamin 1 (po) daily.  If unable to tolerate (po) give 1 amp of multivit (IV) in maintenance IV (if no maintenance IV, 
 contact physician)   
•  Thiamine 100 mg IV/IM/(po) daily x 7 days.  Send first dose orally.  RN to contact pharmacy if parenteral dose desired. 
•  Folic Acid 1 mg IV/(po) daily x 5 days.  Send first dose orally.  RN to contact pharmacy if parenteral dose desired. 
•  Lorazepam/Ativan 1-4 mg (po) q 1 hour prn per documented assessment score 
•  Lorazepam/Ativan 1-4 mg IV q 15 minutes prn per documented assessment score.  May switch to oral when able. 
•  If above ineffective, may initiate  
 •  Lorazepam Maintenance Infusion for MPCU, SPCU, or Critical Care:  
  Lorazepam 250 mg in D5W 250 ml (1 mg/ml):  
  Begin and maintain IV infusion at 2 mg/hr (max of 2 mg/hr)  Decrease rate per Detoxification Score 
  Breakthrough agitation:  1-2 mg IV over 1 minute every 5 minutes prn.   
•  Haloperidol 2-5 mg IV/IM/(po) q 4 hrs prn (use IM only if (po) or IV route not available) 
•  Discontinue Temazepam if ordered. 
CRITICAL CARE ONLY 
  This sedation plan meets the patient’s needs as identified through the pre-sedation assessment.  Re-evaluation  
 completed immediately prior to administration of sedation. 
  In the judgment of the attending physician: 
   •  Informed consent was obtained from patient/family after discussion of sedation options, risks, and alternatives 
      or  
   •  No informed consent was obtained due to medical emergency. 
Sedation Goal: Level 3-4 unless otherwise indicated;      
  1 = Patient anxious, agitated or restless.  
  2 = Patient cooperative, oriented and tranquil     
  3 = Patient asleep, brisk response to loud auditory stimulus 
  4 = Patient asleep, sluggish response to loud auditory stimulus 
  5 = Patient has no response to loud auditory stimulus, but does respond to painful stimulus 
  6 = Patient does not respond to painful stimuli 
 Loading dose only if patient has not received lorazepam prior to initial infusion. 
• Calculation of dose 0.05 mg/kg x    (patient weight) =      mg   
 •  Lorazepam Infusion 0.05 mg/kg x         kg =         mg IV x 1 dose (maximum of 4 mg). 
         May repeat every 3 minutes x 4 doses (total).    
• Maintenance Infusion:  Lorazepam 250 mg in D5W 250 mL (1 mg/mL):’ 
   Calculate previous 1 hour dose.  Start hourly rate at previous 1 hour total. 
Titration: Increase rate q 4 hrs, 10-50% as needed to meet Detoxification Score and Sedation goal.   
  Bolus with lorazepam 1-4 mg IVP with each IV infusion dose increase. 
  Breakthrough agitation:  1-2 mg IV over 1 minute every 3 minutes prn. 
  Decrease rate per Detoxification Score and Sedation goal. 
    If above treatment is ineffective, contact physician. 
• Propofol Infusion.  
• May begin Propofol if Lorazepam Infusion not effective at dose up to 20 mg/hr. 
• Contact physician for order to mechanically ventilate patient. 
• Propofol drip at 5 mcg/kg/min.   Patient weight _______ kg.  Increase dose by 5-10 mcg/kg/min to max of 80 mcg/kg/min. 
• Once sedation goal is achieved, decrease infusion by 10-25% every 8 hrs as tolerated. 
• Turn Propofol Infusion off daily and assess for continued need for sedation.  Restart at 50% of previous dose and titrate prn. 
• Draw baseline triglycerides and every 3 days.  If triglycerides are elevated notify the physician. 
• Consult Dietitian if patient is on Parenteral Nutrition. 
• If Propofol Infusion continues past 3 days, review with physician. 
Orders with a checkbox present must be checked off to be implemented.   
Orders without a checkbox present will be implemented unless stricken out. 
Signature:                      
Date:                Time:        
ORDER SHEET  Scanned (Name)            (Date)             (Time)       
Department of Medicine – Revised:  12/13/2005        ENDO      KDIP      ETC  







ADULT MEDICAL ADMISSION ORDERS 
1.  Admit to       .    Diagnosis                     RN Case Manager 
2.  Implement Protocols:  Pneumonia Protocol (new infiltrate)     Insulin Infusion Protocol Order (non Critical Care) 
       COPD Exacerbation Protocol (no new infiltrate)  Adult Electrolyte Replacement Protocols  
       Heart Failure Protocol       Heparin Weight Based Protocol    
       Alcohol Withdrawal Protocol      Renal Standing Orders  
        Ischemic Stroke Protocol                Oncology Standing Orders      
3.  Hemodialysis on         (date)     See Orders      See PD Orders 
4.  Courtesy notification of patient’s primary physician             of admission.  (Ask patient.) 
 Consult Dr.       regarding           (diagnosis, sign, or symptom). 
5.  Code Status - The patient is full resuscitation status unless the following is ordered: 
Up to the point of cardiopulmonary arrest, maximal therapeutic care will be given. 
1.  No resuscitation / No intubation 
   Resuscitation measures as directed below 
  Resuscitation Medications (must do compressions):    Yes  No 
  Countershock:          Yes  No 
  Intubation for Respiratory Arrest        Yes  No 
2. Patient on a No Code Blue / Do Not Resuscitate order who receive anesthesia/sedation, radiographic contrast, or having a 
 procedure has been informed that he/she will receive full resuscitation. 
3. Have discussed with the patient/family including all relevant facts, information, and circumstances about the resuscitation plan 
of care. 
6.  Allergies:                        
7.  Miscellaneous:  Foley catheter    or     Other                 
8.  Vital signs     Routine      Every 4 hours        Orthostatics on Admit           Other            
     I+O     Daily weight      Daily weight at end of cycle for PD Patient on Cycler 
9.   Activity q shift and document     Bedrest         PT         OT       OOB with assist 
10.  Diet:  NPO    Regular    NAS    Low SAT fat    ADA        Dialysis    PD    Renal   Fluid Restriction    
  Supplements          Texture:         Other:         
11.  Labs:  Chem 8  ( now if not done this admission or  in AM)       CBC ( now if not done this admission or   in AM)  
    Glucometer checks      Other:                         
12.  Diagnostic Studies:              
13.    DVT Heparin 5000 units subcut every 8 hours (0600, 1400, 2200)   *If in Critical Care, use Critical Care DVT Protocol. 
         Sequential Compression Stockings            TEDS  ( Thigh high    Knee high)     
14.   Stress Ulcer Prophylaxis: Famotidine 20 mg po/IV/NG BID.  Send first dose orally.  RN to contact pharmacy if parenteral/NG 
    dosage form desired.  *If in Critical Care, use Critical Care Stress Ulcer Protocol. 
15.  IV:                                 Saline Lock 
16.  Medications:  Renal Dosing Protocol Applies per Pharmacy 
  Medications as ordered by physician on Dialysis Medication Order Sheet.  Nurse to file with Order Sheets. 
  All insulin orders must be written by physician (see Insulin Order Sheet) 
  Acetaminophen 650 mg (po) or per rectum q 4 hrs prn pain or fever 
  Temazepam 7.5-30 mg q HS prn sleep.  May repeat dose in 1 hr.  Max dose 30 mg.  Begin 7.5 mg for patients >70 years old. 
  MOM 30 ml (po) daily prn or  Bisacodyl suppository (R) daily prn or  TWE or Fleet enema daily prn constipation 
  Dolasetron 12.5 mg IV q 8 hrs prn nausea  
  O2 prn per nasal canula to maintain sats >90%.  Titrate per RT Protocol.     Do not exceed       L/minute 
17. If patient is on warfarin and followed by the CentraCare River Campus Anticoagulation Clinic, notify them (x 52823) of admission. 
Orders with a checkbox present must be checked off to be implemented.   
Orders without a checkbox present will be implemented unless stricken out. 
Signature:                       
Date:               Time:          
ORDER SHEET  Scanned (Name)           (Date)            (Time)     
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This section replaces the need for 






ALLERGY   NO    YES         WT.          (kg.)  HT.      
IF YES, PLEASE STATE  
CRITICAL CARE ADMISSION ORDERS 
• Contact Critical Care Practice Nurse if on Intensivist Service pager # 229-6438 or cell phone # 250-9630. 
• Daily Goal Sheet at bedside. 
• If on Mechanical Ventilation, initiate Vent Bundle. 
• Medications: 
 • Flush peripheral access with Normal Saline flush 2 mL q 8 hrs 
 • If patient has central line, flush unused ports with Heparin 100 units/mL to each unused port daily 
PROTOCOLS: 
 •  Deep Vein Thrombosis Prophylaxis Protocol 
   Exclusion Criteria for Heparin Administration 
 •  Active bleeding        •  Hypersensitivity to Heparin or Low Molecular Weight Based Heparin 
   •  INR > 1.5              •  Spinal tap or epidural anesthesia within 7 days  
   •  Intracranial surgery within 6 weeks     •  Heparin induced thrombocytopenia  
   •  Intraocular surgery within 6 weeks      •  *MAJOR TRAUMA/CHI/Intracranial bleed* 
          •  Uncontrolled Hypertension diastolic BP >110 mmHg or systolic BP > 200 mmHg 
 1.  If patient has NONE of the above exclusion criteria:  Administer heparin 5000 units subcutaneously q 8 hrs 
      2.  If patient has exclusion criteria:  Place sequential compression stockings 
 •  Stress Ulcer Prophylaxis Protocol 
   If any of the following conditions are present, then begin Famotidine (as below). 
   •  Sepsis              •  Patients with Glasgow Coma Scale <10 
   •  Mechanical Ventilation expected or actual > 48 hrs     •  Brain or Spinal Cord Injury Patients 
   •  Patients with Hx of UGI ulcer and or bleed within 1 year     •  Coagulopathy: platelet count < 50,000 mm3
       •  Patients receiving high dose corticosteroids defined as:        INR > 1.5 
    Hydrocortisone > 250 mg per day          
    Prednisone > 60 mg per day 
    Methylprednisolone > 50 mg per day  
   •  Patients currently receiving NSAIDs 
  Famotidine 20 mg (po)/IV/NG BID (if authorized above). 
   • Pharmacy may adjust dose per Renal Dosing Protocol 
   • If patient is allergic to famotidine or any H2 blocker medication: 
   1. Pantoprazole 40 mg (po)/IV daily if no NG present 
    or  
2. Lansoprazole Oral Suspension 30 mg per NG daily 
•  Anxiety/Pain Protocol 
  Pneumonia Protocol (Please check one    High Risk for Pseudomonas  or   Low Risk for Pseudomonas 
 Drotrecogin Alfa (Xigris) Protocol 
 Severe Sepsis Bundle 
 Glucose Control Protocol 
 Methylprednisolone for Acute Spinal Cord Injury Protocol 
 
 
Orders with a checkbox present must be checked off to be implemented.   
Orders without a checkbox present will be implemented unless stricken out. 
 
Signature:                       
 
Date:               Time:          
ORDER SHEET   Scanned (Name)            (Date)       (Time)    
Department of Medicine – Revised:  12/16/2005    
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